Human Neural Progenitors Expressing GDNF Enhance Retinal Protection in a Rodent Model of Retinal Degeneration
Stem Cells Translational Medicine · 2023
DOI: 10.1093/stcltm/szad054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2023. Verfasst von Saba Shahin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Board of Governors Regenerative Medicine Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Retinal Degeneration. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: California Institute Regenerative Medicine, Board of Governors Regenerative Medicine Institute at Cedars-Sinai Medical Center.
Abstract (Originalsprache)
Stem cell therapy for retinal degenerative diseases has been extensively tested in preclinical and clinical studies. However, preclinical studies performed in animal models at the early stage of disease do not optimally translate to patients that present to the clinic at a later stage of disease. As the retina degenerates, inflammation and oxidative stress increase and trophic factor support declines. Testing stem cell therapies in animal models at a clinically relevant stage is critical for translation to the clinic. Human neural progenitor cells (hNPC) and hNPC engineered to stably express GDNF (hNPCGDNF) were subretinally injected into the Royal College of Surgeon (RCS) rats, a well-established model for retinal degeneration, at early and later stages of the disease. hNPCGDNF treatment at the early stage of retinal degeneration provided enhanced visual function compared to hNPC alone. Treatment with both cell types resulted in preserved retinal morphology compared to controls. hNPCGDNF treatment led to significantly broader photoreceptor protection than hNPC treatment at both early and later times of intervention. The phagocytic role of hNPC appears to support RPE cell functions and the secreted GDNF offers neuroprotection and enables the extended survival of photoreceptor cells in transplanted animal eyes. Donor cells in the RCS rat retina survived with only limited proliferation, and hNPCGDNF produced GDNF in vivo. Cell treatment led to significant changes in various pathways related to cell survival, antioxidative stress, phagocytosis, and autophagy. A combined stem cell and trophic factor therapy holds great promise for treating retinal degenerative diseases including retinitis pigmentosa and age-related macular degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Board of Governors Regenerative Medicine Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- David Geffen School of Medicine, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
ORCID-Profile: Shaomei Wang
Förderung
- California Institute Regenerative Medicine
- Board of Governors Regenerative Medicine Institute at Cedars-Sinai Medical Center
Zitieren
APA
Shahin, S., Tan, P., Chetsawang, J., Lu, B., Svendsen, S., Ramirez, S., Conniff, T., Alfaro, J. S., Fernandez, M., Fulton, A., Laperle, A. H., Svendsen, C. N., & Wang, S. (2023). Human Neural Progenitors Expressing GDNF Enhance Retinal Protection in a Rodent Model of Retinal Degeneration. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szad054
Vancouver
Shahin S, Tan P, Chetsawang J, Lu B, Svendsen S, Ramirez S, et al. Human Neural Progenitors Expressing GDNF Enhance Retinal Protection in a Rodent Model of Retinal Degeneration. Stem Cells Translational Medicine. 2023. doi:10.1093/stcltm/szad054
BibTeX
@article{Shahin2023,
author = {Shahin, Saba and Tan, Patrick and Chetsawang, Jason and Lu, Bin and Svendsen, Soshana and Ramirez, Stephany and Conniff, Trevor and Alfaro, Jorge S and Fernandez, Michael and Fulton, Aaron and Laperle, Alexander H and Svendsen, Clive N and Wang, Shaomei},
title = {Human Neural Progenitors Expressing GDNF Enhance Retinal Protection in a Rodent Model of Retinal Degeneration},
journal = {Stem Cells Translational Medicine},
year = {2023},
doi = {10.1093/stcltm/szad054}
}
EUVIMED